PortfoliosLab logoPortfoliosLab logo
LHX vs. ABT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LHX vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LHX achieves a 5.89% return, which is significantly higher than ABT's -26.72% return. Over the past 10 years, LHX has outperformed ABT with an annualized return of 16.49%, while ABT has yielded a comparatively lower 10.82% annualized return.


LHX

1D
2.09%
1M
2.36%
YTD
5.89%
6M
10.82%
1Y
29.39%
3Y*
21.50%
5Y*
8.87%
10Y*
16.49%

ABT

1D
4.36%
1M
4.14%
YTD
-26.72%
6M
-26.78%
1Y
-30.33%
3Y*
-2.42%
5Y*
-1.82%
10Y*
10.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LHX vs. ABT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LHX
L3Harris Technologies, Inc.
5.89%42.28%1.88%3.67%-0.48%14.98%-2.76%49.21%-3.38%40.80%
ABT
Abbott Laboratories
-26.72%12.87%4.81%2.26%-20.68%30.53%28.04%22.08%29.06%52.03%

Correlation

The correlation between LHX and ABT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Apr 7, 1983

0.24

Fundamentals

EPS

LHX:

$12.29

ABT:

$3.59

PE Ratio

LHX:

25.21

ABT:

25.29

PEG Ratio

LHX:

12.93

ABT:

1.58

PS Ratio

LHX:

1.94

ABT:

3.52

Total Revenue (TTM)

LHX:

$22.48B

ABT:

$45.13B

Gross Profit (TTM)

LHX:

$5.50B

ABT:

$25.45B

EBITDA (TTM)

LHX:

$3.32B

ABT:

$10.80B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LHX vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LHX
LHX Risk / Return Rank: 7171
Overall Rank
LHX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
LHX Sortino Ratio Rank: 7171
Sortino Ratio Rank
LHX Omega Ratio Rank: 6969
Omega Ratio Rank
LHX Calmar Ratio Rank: 6969
Calmar Ratio Rank
LHX Martin Ratio Rank: 7272
Martin Ratio Rank

ABT
ABT Risk / Return Rank: 55
Overall Rank
ABT Sharpe Ratio Rank: 22
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 44
Sortino Ratio Rank
ABT Omega Ratio Rank: 44
Omega Ratio Rank
ABT Calmar Ratio Rank: 1212
Calmar Ratio Rank
ABT Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LHX vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LHXABTDifference
Sharpe ratioReturn per unit of total volatility

+2.47

Sortino ratioReturn per unit of downside risk

+3.44

Omega ratioGain probability vs. loss probability

1.21

0.78

+0.44

Calmar ratioReturn relative to maximum drawdown

1.44

-0.78

+2.22

Martin ratioReturn relative to average drawdown

4.00

-1.79

+5.79

LHX vs. ABT - Sharpe Ratio Comparison

The current LHX Sharpe Ratio is 1.22, which is higher than the ABT Sharpe Ratio of -1.25. The chart below compares the historical Sharpe Ratios of LHX and ABT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LHXABTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.22

-1.25

+2.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.37

-0.08

+0.46

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.65

0.46

+0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.49

-0.17

Drawdowns

LHX vs. ABT - Drawdown Comparison

The maximum LHX drawdown since its inception was -69.82%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for LHX and ABT.


Loading charts...

Drawdown Indicators


LHXABTDifference

Max Drawdown

Largest peak-to-trough decline

-69.82%

-45.66%

-24.16%

Max Drawdown (1Y)

Largest decline over 1 year

-20.55%

-38.99%

+18.44%

Max Drawdown (3Y)

Largest decline over 3 years

-25.98%

-39.64%

+13.66%

Max Drawdown (5Y)

Largest decline over 5 years

-38.16%

-39.64%

+1.48%

Max Drawdown (10Y)

Largest decline over 10 years

-38.16%

-39.64%

+1.48%

Current Drawdown

Current decline from peak

-17.87%

-33.63%

+15.76%

Average Drawdown

Average peak-to-trough decline

-21.33%

-10.83%

-10.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.37%

16.98%

-9.61%

Volatility

LHX vs. ABT - Volatility Comparison

The current volatility for L3Harris Technologies, Inc. (LHX) is 6.36%, while Abbott Laboratories (ABT) has a volatility of 8.48%. This indicates that LHX experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LHXABTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.36%

8.48%

-2.12%

Volatility (6M)

Calculated over the trailing 6-month period

19.71%

19.45%

+0.26%

Volatility (1Y)

Calculated over the trailing 1-year period

24.22%

24.38%

-0.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.91%

22.05%

+1.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.41%

23.66%

+1.75%

Dividends

LHX vs. ABT - Dividend Comparison

LHX's dividend yield for the trailing twelve months is around 1.18%, less than ABT's 2.69% yield.


PositionTTM20252024202320222021202020192018201720162015
ABT
Abbott Laboratories
2.69%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
LHX
L3Harris Technologies, Inc.
1.18%1.64%2.21%2.17%2.15%1.91%1.80%1.45%1.86%1.55%2.01%2.23%

Financials

LHX vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between L3Harris Technologies, Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


4.00B6.00B8.00B10.00B12.00B20222023202420252026
5.74B
11.16B
(LHX) Total Revenue
(ABT) Total Revenue
Values in USD except per share items

LHX vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between L3Harris Technologies, Inc. and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%20222023202420252026
24.4%
56.3%
Portfolio components
LHX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, L3Harris Technologies, Inc. reported a gross profit of 1.40B and revenue of 5.74B. Therefore, the gross margin over that period was 24.4%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.

LHX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, L3Harris Technologies, Inc. reported an operating income of 652.00M and revenue of 5.74B, resulting in an operating margin of 11.4%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.

LHX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, L3Harris Technologies, Inc. reported a net income of 512.00M and revenue of 5.74B, resulting in a net margin of 8.9%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.


Frequently Asked Questions


LHX and ABT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABT has higher volatility (8.48%) compared to LHX (6.36%). In terms of maximum drawdown, LHX dropped -69.82% vs ABT's -45.66%.

LHX currently has the higher Sharpe Ratio (1.22 vs -1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LHX and ABT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer